Close Menu

360Dx

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution

Premium

Diaceutics Developing New Platform to Improve Access to Precision Medicine

Premium

The DXRX marketplace, planned for launch in the fourth quarter of 2020, will provide a way for pharmaceutical companies, diagnostic firms, and laboratories to collaborate.

Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions

Premium

New data shows that the test could eventually be useful in helping younger women avoid chemotherapy in the neoadjuvant setting.

AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing

More than 70 percent of labs surveyed experienced supply chain interruptions, forcing them to validate three or more diagnostic testing methods.

What's Popular?

  1. FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

  2. Siemens Healthineers Receives FDA Emergency Use Authorizations for Coronavirus Total Antibody Test

  3. Healgen Gets FDA Emergency Use Authorization for Coronavirus Immunoassay

  4. At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution

    Premium

  5. Sema4 Forms Coronavirus Testing Alliance With Connecticut

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.